Clinical trials: Retroperitoneal Sarcoma
Retroperitoneal Sarcoma, Retroperitoneal Fibrosis
Distinguishing Retroperitoneal Fibrosis and Sarcoma from Other Retroperitoneal Diseases Via Radiomics
A retrospective study utilizing archived CT scans of patients diagnosed with retroperitoneal fibrosis, sarcoma or other malignancies (i.e.
- Trial name
- NCT06741423
- Testing
- Radiomics Algortihm
- Where
- 2 sites in China, Germany
- Volunteers
- 600 people
- Sponsor
- Heidelberg University
Primary Retroperitoneal Sarcoma
Survival and Prognostic Factors of Primary Retroperitoneal Sarcomas After Surgery: a Single-center Experience
he percentage of retroperitoneal sarcomas (RPS) among all soft tissue sarcomas ranges from 10%-15%. Surgery remains the gold standard for RPS.
- Trial name
- NCT06396962
- Testing
- WANG DAORONG
- Where
- China
- Volunteers
- 110 people
- Sponsor
- Northern Jiangsu People's Hospital
Peritoneal Neoplasms, Retroperitoneal Neoplasms
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer
There has been no successful treatment of diffuse peritoneal metastasis or carcinomatosis, in childhood tumors. Once this advanced stage of disease is evident, survival is measured in weeks.
- Conditions
- Peritoneal Neoplasms, Retroperitoneal Neoplasms, Gastrointestinal Neoplasms, Adenocarcinoma
- Trial name
- NCT00436657
- Testing
- CHPP of Cisplatin, Abdominal Surgery
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- M.D. Anderson Cancer Center